Abstract
Prolactinomas are the most common type of functional pituitary tumor. The present manuscript is an update on the treatment modalities for prolactinomas. Effective hyperprolactinemia treatment is of great importance, due to its potential deleterious effects including infertility, gonadal dysfunction and osteoporosis. Dopamine agonist therapy is the first line of treatment for prolactinomas; recurrence of disease after cessation of the drug may occur in patients. Its safety profile remains high, allowing its use during pregnancy.
Keywords:
Prolactinomas, dopamine agonist, pituitary tumor, Endoscopic endonasal transsphenoidal surgery, Radiosurgery
Downloads
Download data is not yet available.
How to Cite
María Margarita, C. H., María Valeria, J. B., María Fernanda, A. M., Jorge Miguel, D. L., Alejandra, G. V. K., Karen Alejandra, G. V., … Jurado Luis, S. (2018). Update Treatment for Prolactinoma. International Journal of Innovative Research in Medical Science, 3(06), 2087 to 2088. https://doi.org/10.23958/ijirms/vol03-i06/08
Copyrights & License
Copyright © 2018 Chávez Hernández María Margarita Jiménez Báez María Valeria Armijo Medina María Fernanda Domínguez Leyva Jorge Miguel Góngora Valencia Karen Alejandra Góngora Valencia Karen Alejandra Guerra Rentería Sergio Geovanni Sandoval Jurado Luis this is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This work is licensed under a Creative Commons Attribution 4.0 International License.
